Stock Market & Financial Investment News

News Breaks October 17, 2012 06:47 EDT DBD Diebold downgraded to Underweight from Neutral at JPMorgan JPMorgan downgraded Diebold based on valuation following the company's Q3 profit warning. Price target is $31. News For DBD From The Last 14 Days Check below for free stories on DBD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 14, 2013 10:01 EDT DBD On The Fly: Analyst Initiation Summary Subscribe for More Information 06:17 EDT DBD Diebold initiated with a Neutral at Susquehanna Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.